Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2025-03-07 Major Shareholding Noti…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly identified as an 'RNS Number' filing from the London Stock Exchange. The content is a 'TR-1: Standard form for notification of major holdings' concerning Sand Grove Capital Management LLP crossing a threshold of voting rights (10.180000%). This type of mandatory disclosure regarding changes in significant share ownership directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2025-03-07 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly identified as an 'RNS Number' filing from the London Stock Exchange. The content is a 'TR-1: Standard form for notification of major holdings' concerning Sand Grove Capital Management LLP acquiring voting rights in Alliance Pharma PLC, crossing a threshold. This type of filing, which reports changes in significant share ownership, directly corresponds to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2025-03-03 English
Confirmation of Adjournment
M&A Activity Classification · 98% confidence The document is an RNS announcement from Alliance Pharma PLC dated February 28, 2025, concerning a 'RECOMMENDED ACQUISITION' of Alliance Pharma PLC by Aegros Bidco Limited, to be effected by a 'scheme of arrangement under Part 26 of the Companies Act 2006'. It specifically discusses the 'ADJOURNMENT OF COURT MEETING AND GENERAL MEETING' related to this acquisition, referencing a previously published 'Scheme Document'. Since the core subject is a takeover/merger proposal ('Acquisition') and the document is a formal regulatory announcement (RNS Number: 9318Y), it strongly aligns with the M&A Activity category (TAR). Although it is an RNS, the specific content about a takeover proposal makes TAR more precise than the general RNS fallback.
2025-02-28 English
Adjournment of Court Meeting and General Meeting
M&A Activity Classification · 98% confidence The document is an RNS announcement dated February 26, 2025, concerning a 'RECOMMENDED ACQUISITION' of Alliance Pharma PLC by Aegros Bidco Limited, implemented via a Scheme of Arrangement. The core content is an 'ADJOURNMENT OF THE COURT MEETING AND GENERAL MEETING AND UPDATE ON REGULATORY CONDITIONS'. This is a specific corporate action announcement related to a takeover/merger proposal, which aligns directly with the definition for M&A Activity (TAR). Although it is an RNS announcement, the subject matter is highly specific to a takeover, making TAR a more precise classification than the general fallback RNS.
2025-02-26 English
Publication of Scheme Document
M&A Activity Classification · 99% confidence The document is an RNS announcement dated January 31, 2025, regarding a 'RECOMMENDED ACQUISITION' of Alliance Pharma PLC by Aegros Bidco Limited. It explicitly states the 'PUBLICATION OF SCHEME DOCUMENT' related to a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act. This content directly relates to a merger or takeover proposal, which aligns with the definition of M&A Activity (TAR). Although it announces the publication of a Scheme Document, the core subject matter is the takeover itself, making TAR more specific than RPA or RNS, especially given the detailed discussion of the Scheme, Alternative Offer, and voting procedures related to the acquisition.
2025-01-31 English
Full Year Trading Update
Earnings Release Classification · 99% confidence The document is titled 'Full Year Trading Update' for the year ended 31 December 2024. It provides unaudited financial highlights (revenues, profit expectations) for the full year, explicitly stating it is 'ahead of the announcement of the Group's audited results.' This structure—a brief, high-level summary of annual performance released before the full audited report—is characteristic of an Earnings Release (ER). Although it covers a full year, it is not the comprehensive 10-K, nor is it a transcript or a formal audit report. It is an early announcement of financial results. FY 2024
2025-01-31 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.